CORCEPT THERAPEUTICS INC Debt Securities, Available-for-sale
CORCEPT THERAPEUTICS INC (CORT) had Debt Securities, Available-for-sale of $573.94 million as of 2024-12-31, per its 10-K filed 2025-02-26.
Financial Statements › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2025-02-26
- 2024-12-31: Debt Securities, Available-for-sale $573.94M.
- 2024-03-31: Debt Securities, Available-for-sale $414.18M.
- 2023-12-31: Debt Securities, Available-for-sale $387.02M.
- 2023-03-31: Debt Securities, Available-for-sale $425.05M.
| Period end | Debt Securities, Available-for-sale |
|---|---|
| 2024-12-31 | $573.94M 10-K · filed 2025-02-26 |
| 2024-03-31 | $414.18M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $387.02M 10-K · filed 2025-02-26 |
| 2023-03-31 | $425.05M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $406.67M 10-K · filed 2024-02-15 |
| 2022-09-30 | $375.89M 10-Q · filed 2022-11-03 |
| 2022-03-31 | $330.50M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $303.28M 10-K · filed 2023-02-28 |
| 2021-09-30 | $473.67M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $445.51M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $432.95M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $451.23M 10-K · filed 2022-02-15 |
| 2020-09-30 | $434.72M 10-Q · filed 2020-11-03 |
| 2020-06-30 | $385.79M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $331.75M 10-Q · filed 2020-05-04 |
| 2019-12-31 | $302.51M 10-K · filed 2021-02-23 |
| 2019-09-30 | $252.09M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $210.83M 10-Q · filed 2019-08-01 |
| 2018-12-31 | $192.21M 10-K · filed 2020-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |